搜尋
NewAmsterdam Pharma Company NV
NAMS添加自選
33.890USD
+0.020+0.06%
收盤 06/30, 16:00（美東）報價延遲15分鐘
3.96B總市值
虧損本益比TTM
股東統計
更新時間: 5月13日 週三
更新時間: 5月13日 週三
持股股東
股東類型
持股股東
持股股東
佔比
Frazier Life Sciences Management, L.P.
14.49%
Capital World Investors
8.54%
RA Capital Management, LP
8.17%
Forbion Capital Partners
7.87%
Fidelity Management & Research Company LLC
5.03%
其他
55.90%
持股股東
持股股東
佔比
Frazier Life Sciences Management, L.P.
14.49%
Capital World Investors
8.54%
RA Capital Management, LP
8.17%
Forbion Capital Partners
7.87%
Fidelity Management & Research Company LLC
5.03%
其他
55.90%
股東類型
持股股東
佔比
Investment Advisor
29.84%
Investment Advisor/Hedge Fund
20.74%
Venture Capital
19.33%
Private Equity
14.49%
Hedge Fund
12.38%
Family Office
2.63%
Research Firm
2.49%
Individual Investor
0.99%
Sovereign Wealth Fund
0.97%
機構持股
更新時間: 4月1日 週三
更新時間: 4月1日 週三
報告期間
機構數
持股數
持股佔比
持股變動
2026Q1
366
128.70M
110.09%
+2.43M
2025Q4
317
118.25M
104.29%
-6.54M
2025Q3
283
121.74M
107.54%
+4.12M
2025Q2
263
127.89M
114.87%
+4.67M
2025Q1
255
126.71M
112.87%
+7.17M
2024Q4
216
108.34M
98.72%
+13.96M
2024Q3
194
82.73M
88.90%
-12.05M
2024Q2
184
81.92M
90.19%
-12.22M
2024Q1
155
81.92M
90.50%
-4.21M
2023Q4
117
72.34M
86.57%
-9.73M
查看更多
股東持股明細
名稱
持股數
佔比
持股變動
變動比例
公告日期
Frazier Life Sciences Management, L.P.
16.94M
14.74%
+241.82K
+1.45%
Dec 31, 2025
Capital World Investors
9.98M
8.68%
+161.29K
+1.64%
Dec 31, 2025
RA Capital Management, LP
9.55M
8.31%
-588.75K
-5.81%
Dec 31, 2025
Forbion Capital Partners
9.20M
8%
-13.48K
-0.15%
Dec 31, 2025
Fidelity Management & Research Company LLC
5.87M
5.11%
+480.89K
+8.92%
Dec 31, 2025
Bain Capital Life Sciences Investors, LLC
5.67M
4.93%
-4.80M
-45.83%
Dec 31, 2025
Wellington Management Company, LLP
5.03M
4.38%
+1.01M
+25.20%
Dec 31, 2025
Viking Global Investors LP
4.20M
3.66%
-2.27M
-35.09%
Dec 31, 2025
Deerfield Management Company, L.P.
4.16M
3.62%
-101.90K
-2.39%
Dec 31, 2025
Duquesne Family Office LLC
3.07M
2.67%
+1.15M
+59.60%
Dec 31, 2025
查看更多
持股ETF
更新時間: 12月6日 週六
更新時間: 12月6日 週六
機構名稱
佔比
Global X Guru Index ETF
1.82%
ALPS Medical Breakthroughs ETF
1.81%
Virtus LifeSci Biotech Clinical Trials ETF
1.22%
First Trust Small Cap Growth AlphaDEX Fund
1.05%
First Trust NASDAQ Pharmaceuticals ETF
0.83%
Capital Group US Small and Mid Cap ETF
0.68%
ProShares Ultra Nasdaq Biotechnology
0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
0.55%
First Trust Small Cap Core Alphadex Fund
0.43%
Invesco Nasdaq Biotechnology ETF
0.42%
查看更多
Global X Guru Index ETF
佔比1.82%
ALPS Medical Breakthroughs ETF
佔比1.81%
Virtus LifeSci Biotech Clinical Trials ETF
佔比1.22%
First Trust Small Cap Growth AlphaDEX Fund
佔比1.05%
First Trust NASDAQ Pharmaceuticals ETF
佔比0.83%
Capital Group US Small and Mid Cap ETF
佔比0.68%
ProShares Ultra Nasdaq Biotechnology
佔比0.57%
Invesco Dorsey Wright SmallCap Momentum ETF
佔比0.55%
First Trust Small Cap Core Alphadex Fund
佔比0.43%
Invesco Nasdaq Biotechnology ETF
佔比0.42%